Glaucoma: lasers and new shunt data

- At AAO sessions, Joel Schuman and others emphasised expanding office‑based laser options, including direct selective laser trabeculoplasty (DSLT), as lower‑burden alternatives to chronic topical therapy. - Separately, Avisi Technologies reported positive 12‑month pilot results for its VisiPlate aqueous shunt in open‑angle glaucoma, showing early efficacy signals but without comparative or long‑term safety data. - The field is trending toward earlier, less invasive pressure control to reduce drop dependence; watch DSLT uptake and VisiPlate 12‑month outcomes as evidence evolves. (europe.ophthalmologytimes.com) (ophthalmologytimes.com)